Notably, our recent study revealed the aberrant pathways at protein phosphorylation levels in the lungs of silicosis mice and identified the phosphorylation of EGFR (p-EGFR) and SYK (p-SYK) as potential therapeutic targets in the progression of silicosis (15). This evidence concerns the gene EGFR and silicosis.